跳至主要内容
临床试验/NCT06016465
NCT06016465招募中早期 1 期

Does Nerve Block Plus Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hours Better Than Nerve Block Alone?

Texas Tech University Health Sciences Center, El Paso2 个研究点 分布在 1 个国家目标入组 84 人开始时间: 2023年9月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
招募中
发起方
入组人数
84
试验地点
2
主要终点
Recurrence of headache

研究概览

简要总结

For some patients who come to the emergency department for treatment of a migraine headache, peripheral headache nerve blocks (PHNB) have proven to be an efficient and effective treatment for headache relief. Previous studies have demonstrated that adding steroids as an adjunct treatment to standard migraine treatment can reduce recurrence of headaches in the subsequent few days.

详细描述

Previous studies have provided evidence that administering steroids in addition to standard migraine headache treatment in the emergency department may reduce the recurrence of the headache within 24-72 hours. The standard migraine treatments in previous studies have been varied and include 5-HT receptor agonists, dopamine antagonists, dihydroergotamine, NSAIDS, and opioid analgesics. The steroids added to the standard treatment have been prednisone and dexamethasone (both IV and oral).

This is the first study to examine the combination of peripheral nerve block as the primary treatment of migraine followed by oral dexamethasone to prevent recurrence.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

study drug pills (dexamethasone or placebo) will be placed in identical colored capsules and then into numbered packets. Only pharmacist will be unblinded.

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Meet ICHD-3 Migraine Headache Criteria
  • Had a minimum 5-point reduction in headache intensity after nerve block(s) or post- block pain score of 0 to 2
  • Nerve block performed with bupivacaine 0.5%

排除标准

  • Head trauma
  • Suspicion of secondary headache (i.e. stroke, known tumor, glaucoma)
  • Headache in the setting of viral syndrome
  • Chronically on steroids
  • Known allergy to dexamethasone
  • Unable to reach the patient by phone or text for follow-up
  • Gestational diabetes or other uncontrolled diabetes
  • Known to be immunocompromised

研究组 & 干预措施

Placebo

Placebo Comparator

Single oral dose of placebo pill

干预措施: Placebo (Drug)

Dexamethasone

Experimental

single oral dose of dexamethasone (8mg)

干预措施: Dexamethasone Oral (Drug)

结局指标

主要结局

Recurrence of headache

时间窗: 72-96 hours post treatment

Subjects will be contacted 72 hrs post treatment to determine if migraine headache has recurred

次要结局

  • Early recurrence headache and timing(72-96hrs post treatment)
  • side effects of dexamethasone identified if any(72-96 hrs post treatment)

研究者

发起方
Texas Tech University Health Sciences Center, El Paso
申办方类型
Other
责任方
Principal Investigator
主要研究者

Edward Michelson, MD

Professor and Chair Dept of Emergency Medicine

Texas Tech University Health Sciences Center, El Paso

研究点 (2)

Loading locations...

相似试验

Does Nerve Block + Oral Dexamethasone Reduce... | 临床试验